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ABSTRACT We present evidence that virus-specific
RNA is present in polyribosomes of transformed cells
replicating the murine sarcoma-leukemia virus complex
and that it serves as messenger RNA for the synthesis of
viral-coded proteins. Both virus-specific RNA (detected
by hybridization with the [3H]DNA product of the viral
RNA-directed DNA polymerase) and nascent viral poly-
peptides (measured by precipitation with antiserum to
purified virus) were found in membrane-bound and free
polyribosomes. Membrane-bound polyribosomes con-
tained a higher content of both virus-specific RNA and
nascent viral polypeptides. From 60 to 70% of viral RNA
sequences were released from polyribosomes with EDTA,
consistent with a function as messenger RNA. Maximum
amounts of both virus-specific RNA and nascent viral
polypeptides were found in the polyribosome region sedi-
menting at about 350 S.
Cells transformed by RNA tumor viruses possess virus-
specific RNA sequences (1-5), but direct proof for their func-
tion as mRNA in translation is lacking. To understand the
role of virus-specific RNA in the synthesis of viral structural
proteins, we have studied different size classes of free and
membrane bound polyribosomes in rat cells transformed by
murine sarcoma virus that produce the murine sarcoma-leu-
kemia virus complex [MSV(MLV)]. Virus-specific RNA was
detected by molecular hybridization with the [3H]DNA
product of the viral RNA-directed DNA polymerase. Nascent
viral polypeptides were detected by immunological precipita-
tion with antiserum directed against purified virus (6). Our
results suggest that virus-specific RNA functions as mRNA
for the synthesis of virion polypeptides in free and membrane-
bound polyribosomes.
MATERIALS AND METHODS
Buffers. The following buffers were used: Tris buffer [20
mM Tris.HCl (pH 7.5) at 4°-50 mM KC1-5 mM MgC12];
RSB-CC [10 mM Tris * HCl (pH 7.5) at 4°-10 mM NaCl-1.5
mM MgCl2-3.6 mM CaCl2-200 ug/ml of cycloheximide];
phosphate-buffered saline (137 mM NaCl-2.7 mM KC1-8.1
mM Na2HPO4-1.47 mM KH2PO4); TKM [50 mM Tris * HC1
(pH 7.5) at 20-25 mM KC1-5 mM MgCl2]; puromycin buffer
[1 mM puromycin, 1 M KCl, 50 mM Tris *HC1 (pH 7.5) at
40, 5 mM MgCl2, 100 ug/ml of bovine-serum albumin]; Na
Abbreviations: M-MSV(MLV), Moloney strain of murine sar-
coma-leukemia virus; RSB-CC, reticulocyte standard buffer
with CaCI2 and cycloheximide.
* On leave from the Istituto di Patologia generale dell Universita'
di Napoli, Naples, Italy.
dodecyl sulfate buffer [10mM Tris HCl (pH 7.0) at 25°-100
mM NaCl-1 mM EDTA-0.5% Na dodecyl sulfate]. All solu-
tions were sterilized by autoclaving except bovine-serum al-
bumin.
Cells and Viruses. Transformed rat cells (78A1) producing
M-MSV(MLV), uninfected Wistar rat cells, and rat cells
transformed by adenovirus 2 (8617), were grown as described
(6, 7). Labeled M-MSV(MLV) was isolated from the culture
medium of 78A1 cells grown for 48 hr in phosphate-free
Eagle's medium containing 100 uCi/ml of carrier-free 32p or in
Eagle's medium with 10 uCi/ml of [3H]uridine (40-50 Ci/
mmol, NEN Chemicals) (6,8).
Isolation of Free and Membrane-Bound Polyribosomes. Un-
labeled polyribosomes were isolated from confluent mono-
layers of 78A1 cells, and labeled polyribosomes from 78A1 or
8617 cells grown in suspension. To obtain maximum yields of
undegraded polyribosomes and to avoid "runoff" (9-13),
we took the following precautions: cultures were fed 4 hr
before harvesting (9, 10), 200 ug/ml of cycloheximide was
added during harvesting (13) and homogenization of cells, and
a 150,000 X g rat-liver supernatant (S-3) was added through-
out the isolation (14).
Polyribosomes were isolated by two procedures (at 2-4°),
direct layering and pelleting. Direct layering was used when
quantitative recovery was desired, especially for isolation of
small quantities of nascent polypeptides. Pelleting was used
in experiments requiring high resolution and a larger propor-
tion of heavier polysomes. (a) Direct layering: Cells were
washed with phosphate-buffered saline containing cyclohex-
imide (200 ug/ml), swollen for 15 min in five volumes of RSB-
CC plus S-3, and homogenized with 10-20 strokes of a Kontes
Dounce homogenizer (B pestle). Nuclei and cell debris were
removed by centrifugation at 750 X g for 10 min. The post-
nuclear supernatant was centrifuged at 27,000 X g for 5 min
to separate the microsome fraction containing membrane-
bound polyribosomes (15, 16) and the supernatant fluid con-
taining free polyribosomes. The microsome fraction was
solubilized with 1% sodium deoxycholate and 1% Nonidet
P40 to liberate the polyribosomes. (b) Pelleting: Free and
membrane-bound polyribosome fractions, obtained as de-
scribed above, were layered onto a discontinuous sucrose
gradient (14) containing S-3 and centrifuged at 36,000 rpm in
an SW41 rotor or at 45,000 rpm in a titanium 50 rotor of a
Spinco ultracentrifuge for 12-18 hr at 4°. The pellet was sus-
pended in Tris buffer containing 0.1 volumes of S-3, and
clarified by centrifugation at 750 X g for 5 min.
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FIG. 1. Virus-specific RNA in free and membrane-bound polyribosomes. Free (A) and membrane-bound (B) polyribosomes were iso-
lated by pelleting. About 4 A2n0 nm units of free and 1.2 A2on nm units of membrane-bound polyribosomes were layered onto 15-45% (w/v)
sucrose gradients in Tris buffer and centrifuged for 75 min at 36,000 rpm in a SW41 rotor. Fractions (0.5 ml) were collected with con-
tinuous UV monitoring with a Gilford recording spectrophotometer. RNA was extracted from each fraction and hybridized with MSV-
(MLV) [3H]DNA product (2000 dpm) (2). Sedimentation is from right to left.
Release ofmRNA from Polyribosomes. Messenger RNA was
released from free and membrane-bound polyribosomes
(prepared by "pelleting") by suspension in Tris buffer con-
taining 25mM EDTA and 0.1 volumes of S-3.
Extraction of RNA. Pooled or individual fractions of poly-
ribosomes resolved by zonal centrifugation were precipitated
with two volumes of ethanol in the presence of 30 Ag of yeast
RNA and dissolved in Na dodecyl sulfate buffer. The solu-
tion was stirred with a Vortex mixer for 1 min with an equal
volume of water-saturated phenol, and for 30 see with an
equal volume of chloroform-isoamyl alcohol 24:1. After a
centrifugation at low speed, RNA was precipitated from the
aqueous phase with two volumes of ethanol at -20° over-
night and dissolved in 15mM NaCl-1.5mM Na3 citrate.
[3H]DNA Product was prepared by the endogenous, RNA-
directed DNA polymerase reaction (1) of detergent-disrupted
M-MSV(MLV) with [3H]TTP (11-12 Ci/mmol, New En-
gland Nuclear Corp.), using conditions that transcribe most
(80-90%) of the viral genome (Green, unpublished data).
Hybridization. Polyribosomal RNA was annealed with
[3H]DNA (2000 dpm) in 300 mM NaCl-30 mM Na, citrate
(pH 5.5) at 660 for 18 hr. The formation of DNA-RNA hy-
brids was measured by batch elution from hydroxyapatite
(2).
Labeling of Polyribosomes. 3 Liters of 78A1 cells were cen-
trifuged and incubated in 500 ml of leucine-free Eagle's
medium plus 5 MCi/ml of [3H]leucine (30-50 Ci/mmol, New
England Nuclear Corp.) for 30 sec. Incorporation was stopped
with 1/5 volume of crushed frozen phosphate-buffered saline
containing cycloheximide (200 Mg/ml). Polyribosomes were
isolated as described above.
Release of Nascent Polypeptides. Polyribosome fractions
from sucrose gradients were centrifuged at 45,000 rpm in a
Spinco Ti5O rotor for 12-18 hr and suspended in 0.2 ml of
puromycin buffer (17). After incubation at 0° for 15 min, the
preparation was layered over 4.0 ml of 1.0 M sucrose and
centrifuged for 1 hr at 40,000 rpm in a Spinco Ti5O rotor.
The upper layer containing released polypeptides was used
for immunoprecipitation.
Immunoprecipitation. Preparations of nascent polypeptides
from free or membrane-bound polyribosomes were incubated
with antiserum against MSV(MLV) in the presence of de-
tergent-disrupted MSV(MLV) (15-20 Mg of protein) and
0.05% Na dodecyl sulfate (6). The antiserum against MSV-
(MLV) was obtained from rabbits inoculated with purified
MSV(MLV) after disruption with Na dodecyl sulfate and
was absorbed with an extract of normal rat-embryo fibro-
blasts. Details of specificity and characterization of anti-
serum against MSV(MLV) have been described (6). As con-
trols, corresponding fractions of nascent polypeptides from
labeled 8617 cells were incubated with the same antiserum.
Immunoprecipitates were dissolved in 10% Na dodecyl sul-
fate and counted. The radioactivity of immunoprecipitates
from 78A1 cell polypeptides were corrected for nonspecific
precipitation by subtraction of the corresponding values
from 8617 cells.
Measurement of Radioactivity. Nitrocellulose membrane
filters containing radioactive hybrids were dried and counted
in 10 ml of toluene containing 0.4% 2,5-bis(2-5-tert-butyl-
benzoxazolyl-thiophene) (BBOT). Aliquots of sucrose gradient
fractions and immunoprecipitates (100 Ml) in 10% Na dodecyl
sulfate were counted in 10 ml of Aquasol (New England
Nuclear Corp.).
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FIG. 2. Dissociation of free polyribosomes and release of virus-specific RNA by EDTA. Polyribosomes isolated by pelleting were sus-
pended in 1.0 ml of Tris buffer. Half (5 A260 m units) served as a control (A) and 0.5 ml was treated with 25 mM EDTA (B). Each sample
was layered on a 15-45% (w/v) sucrose density gradient in Tris buffer (MgCla deleted for EDTA-treated samples) and sedimented as
described in Fig. 1. The recovery of virus-specific RNA was about 50% in EDTA-treated samples, perhaps due to the fower stability of
viral mRNA after release from polyribosomes.
RESULTS
Detection of Virus-Specific RNA in Polyribosomes of Virus-
Producing Cells Transformed by M-MSV. Free (Fig. 1A) and
membrane-bound (Fig. 1B) polyribosomes from 78A1 cells
were fractionated by zonal centrifugation in sucrose density
gradients. RNA was extracted from each polyribosome frac-
tion and annealed to viral [3H]DNA to detect virus-specific
RNA. Virus-specific RNA was detected in all size classes of
polyribosomes (Fig. 1). A major peak of virus-specific RNA
was found at about 350 S in both free and membrane-bound
polyribosomes [size estimated as described (18)1. To provide
evidence that viral RNA in polyribosomes has the properties
of mRNA, duplicate aliquots of free and membrane-bound
polyribosomes were treated with 25 mM EDTA, a procedure
that dissociates polyribosomes and releases mRNA (19). As
shown in Figs. 2 and 3, most of the hybridizable RNA (76%
for free polyribosomes and 62% for membrane-bound poly-
ribosomes) was released from polyribosomes and displaced
towards the top of the gradient.
To eliminate the possibility that contamination of poly-
somes with virus particles was responsible for viral RNA
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FIG. 3. Dissociation of membrane-bound polyribosomes, and
release of virus-specific RNA by EDTA. 1.3 A260 rm units of
polyribosomes were layered on each gradient. See Fig. 2 for fur-
ther details. (A) Untreated; (B) treated with EDTA.
detected1 in polyribosomes, [32p] or [3H]uridine-labeled virus
was mixed with 78A1 cells before homogenization to prepare
free and membrane-bound polyribosomes (microsome frac-
tion). The radioactivity was distributed 60-80% in free poly-
ribosome fraction and 20-40% in the microsomes. The radio-
activity sedimented in the central region of the free poly-
ribosome gradient (7.5-45% sucrose, SW27 rotor, 85 min at
25,000 rpm); for microsomes freed from membranes, the bulk
of the radioactivity sedimented in a region close to the 80S
ribosome peak and at the top of the gradient. However, no
shift of the radioactivity peak was found when free or mem-
brane-bound polyribosomes containing radioactivity derived
from added virions was treated with EDTA. Thus, virus-
specific RNA identified on polyribosomes by hybridization
cannot be due to virion particles cosedimenting with poly-
ribosomes.
Relative Amount of Virus-Specific RNA in Free and Mem-
brane-Bound Polyribosomes. From the A260 nm units of RNA
and the extent of hybridization (Fig. 1), it may be estimated
that 4.3-times as much virus-specific RNA is present in mem-
brane-bound as in free polyribosomes. The hydridization-
saturation experiment presented in Fig. 4 confirms this es-
timate. RNA was isolated from pooled regions in sucrose
gradients of free or membrane-bound polyribosomes, and in-
creasing amounts were annealed with a constant amount of
viral [3H]DNA. Comparison of the RNA concentrations that
give half-maximal hybridization (see Fig. 4) shows that
membrane-bound polyribosomes contain about 4-times as
much virus-specific RNA as do free polyribosomes.
Nascent Viral Polypeptides in Polyribosomes of 78A1 Cells.
To determine whether polyribosomes containing virus-
specific RNA synthesize viral proteins, 78A1 cells were incu-
bated with [ H]leucine for 30 sec to label nascent poly-
peptide chains. Free and membrane-bound polyribosomes
were isolated by the direct layering procedure, and 30% of
the polypeptide radioactivity was released by treatment with
puromycin. The degree of immunoprecipitation of released
polypeptides from free fraction and membrane-bound poly-
ribosomes with completely absorbed antiserum against
MSV(MLV) prepared in rabbits are shown in Fig. 5. The im-
munoprecipitation of released nascent polypeptides in the
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peak fraction from membrane-bound polyribosomes was 10%0,
while that from free polyribosomes was 1%, as obtained from
the peak fraction of free polyribosomes. The highest concen-
tration of viral polypeptide chains was found in the heavy
regions of the gradient (about 350 S in several experiments)
(Fig. 5B), which correspond to the region containing the
highest concentration of virus-specific RNA (Fig. 1B).
DISCUSSION
Virus-specific RNA molecules in cells transformed by and
producing RNA tumor viruses may serve two functions: (i)
precursor to the viral 70S RNA genome, and (ii) mRNA for
synthesis of viral-coded proteins. The presence of virus-
specific RNA in a polyribosome fraction of a mouse-mammary
tumor has been reported (4), but neither its origin nor mes-
senger function has been established. We have described two
lines of evidence that virus-specific RNA in polyribosomes of
78A1 cells function as mRNA: (i) virus-specific RNA as-
sociated with polyribosomes can be released by treatment with
EDTA, and (ii) immunologically reactive viron polypeptides
are synthesized by the same size polyribosomes. Furthermore,
78A1 polyribosomes synthesize polypeptides in vitro that
resemble virion polypeptides by immunological and elec-
trophoretic criteria (20).
From the data used in Fig. 4 and from the calibration curve
showing that half-saturation of [3HJDNA occurs with 0.012
,ug of viral 70S RNA, we calculate that 0.69% of total cellular
RNA and 0.58% of polyribosomal RNA is virus specific.
Since polyribosomal RNA represents about 80% of total
cellular RNA and 70% of virus-specific RNA in polyribo-
somes is mRNA as judged by EDTA release, we estimate that
0.32% of the total cellular RNA is viral mRNA. Thus, about
half of the total virus-specific RNA in 78A1 cells may function
as mRNA.
A peak of virus-specific RNA and immunologically reactive
polypeptides was found in polyribosomes sedimenting at
about 350 S. Similar sedimentation rates were reported for
polyribosomes of ascites cells infected with encephalomyo-
carditis virus (21) whose RNA has a molecular weight of
2.6 X 106 (22). The size of the MSV(MLV) major RNA sub-
units formed by denaturation of the viral 70S RNA genome
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FIG. 4. Hybridization-saturation of RNA from whole cells
(0) and from free (0) and membrane-bound (0), polyribosomes
with MSV(MLV) [3H]DNA. Polyribosomes were obtained by
direct layering, and fractions 4-14 of sucrose gradients of free
and membrane-bound polyribosomes (see Fig. 5A and B) were
pooled for RNA extraction. Increasing amounts of RNA were
annealed with a constant amount (2000 dpm) of ['H]DNA
product.
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FIG. 5. Immunoprecipitation of labeled nascent polypeptides
from free and membrane-bound polyribosomes. Cells were labeled
with [3H]leucine. Polyribosomes were isolated by direct layering
and centrifuged in 7.5-45% (w/v) sucrose density gradients in
Tris buffer for 85 min at 25,000 rpm in a Spinco SW27 rotor.
Nascent polypeptides were released from each gradient fraction
with puromycin and were immunoprecipitated with antiserum
against MSV(MLV). Nonspecific precipitation with the same
serum and the corresponding fractions from 8617 cell polyribo-
somes was subtracted from each fraction of 78A1 polyribosomes.
(A) Free polyribosomes; (B) membrane-bound polyribosomes.
is 35 S, corresponding to 3 X 106 daltons (Tsuchida and Green,
manuscript in preparation). This value is close to that of
encephalomyocarditis virus and is compatible with a poly-
ribosome of 350 S. Virus-specific RNA in smaller polyribo-
somes could be intact viral mRNA loaded with fewer ribo-
somes or breakdown products of viral RNA still bound to
polyribosomes.
Membrane-bound polyribosomes contain a much higher
content of virus-specific RNA and nascent virion polypeptides
than did free polyribosomes per unit of polyribosomal RNA.
However, the absolute content in each polyribosome class is
about the same since 78A1 cells contain 4-times as much free as
membrane-bound polyribosomes (unpublished data). Al-
though membrane-bound polyribosomes have been thought
to function generally in the synthesis of exportable proteins
(23), recent findings suggest other possibilities. For example,
immunoglobulin that is exported from cells is synthesized on
both free and membrane-bound polyribosomes (24). In addi-
tion, the attachment of all newly synthesized RNA to ribo-
somes appears to occur free in the cytoplasm, and subse-
quently a portion of the mRNA ribosome complex attaches
to membranes (25). Furthermore, a recent report suggests
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that free polyribosomes become membrane-bound only when
the growing polypeptide chain has reached a certain length
(26). It is interesting that in our experiments (unpublished
data) and those reported by Vassart (16), nascent polypeptide
chains released from free polyribosomes are smaller on the
average than those released from membrane bound poly-
ribosomes. This finding could represent an additional ex-
planation for the low immunological reactivity of the nascent
chains derived from free polysomes.
Thus, it is possible that the synthesis of RNA tumor virus
proteins is initiated on free polyribosomes, as may be the case
for most cellular proteins, and that virus-specific complexes
attach to membranes to a higher degree than do cellular
polyribosomes. Perhaps the attachment to membranes of
virus-specific polyribosomes is necessitated by maturation of
virion polypeptides, a process that may involve proteolytic
cleavage and glycosylation and may require enzymes present
on microsomes.
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